2026-01-04 - Analysis Report
Okay, here's a comprehensive report on Honeywell International Inc. (HON), based on the data provided:

**1) Return Rate Comparison & Analysis**

*   **Company Overview:** Honeywell International Inc. is a diversified technology and manufacturing company serving customers worldwide with aerospace products and services, building technologies, performance materials and technologies, and safety and productivity solutions.
*   **HON Cumulative Return:** 10.67%
*   **VOO (S&P 500) Cumulative Return:** 91.00%
*   **Divergence:** -81.1 (Relative Divergence: 2.8)

    **Analysis:** HON has significantly underperformed the S&P 500 over the period represented by the cumulative returns. The divergence of -81.1 indicates a substantial difference in performance. The relative divergence of 2.8 suggests that the current divergence is near the lowest point of its historical range compared to the S&P 500.

**Alpha, Beta Analysis Table and Interpretation**

| Year       | CAGR    | MDD    | Alpha   | Beta  | Cap(B) |
|------------|---------|--------|---------|-------|--------|
| 2016-2018  | 2.0%    | 19.7%  | -2.0%   | 0.9   | 83.9   |
| 2017-2019  | 23.0%   | 19.7%  | 5.0%    | 1.0   | 112.4  |
| 2018-2020  | 4.0%    | 19.7%  | -17.0%  | 1.1   | 135.1  |
| 2019-2021  | 17.0%   | 18.8%  | -27.0%  | 1.1   | 132.4  |
| 2020-2022  | 8.0%    | 17.6%  | 10.0%   | 1.0   | 136.1  |
| 2021-2023  | -8.0%   | 17.6%  | -9.0%   | 0.8   | 133.2  |
| 2022-2024  | -1.0%   | 17.0%  | -20.0%  | 0.8   | 143.5  |
| 2023-2025  | -16.0%  | 19.7%  | -78.0%  | 0.8   | 131.5  |

*   **CAGR (Compound Annual Growth Rate):** Shows the average annual growth rate over the specified period.  Note the declining CAGR in more recent periods.
*   **MDD (Maximum Drawdown):**  Represents the largest peak-to-trough decline during the period. MDD remained steady around 17~20%
*   **Alpha:**  Measures the stock's performance relative to a benchmark (likely the S&P 500). Negative alpha suggests underperformance relative to the benchmark. Alpha declined sharply in the latest period.
*   **Beta:** Measures the stock's volatility relative to the market. A beta around 1 indicates that HON's price tends to move similarly to the market. Beta is steadily around 0.8~1.1
*   **Cap(B):**  Likely market capitalization in billions.

**Analysis:** HON's alpha has been negative for several of the periods, indicating underperformance relative to its benchmark. The decreasing CAGR and significantly negative alpha in the 2023-2025 period are concerning. Beta is close to 1.0, suggesting HON's volatility mirrors the market.

**2) Recent Stock Price Fluctuations**

*   **Current Close Price:** 195.88
*   **Previous Close Price:** 195.09
*   **Price Change:** 0.4
*   **5-day SMA:** 196.358
*   **20-day SMA:** 195.413
*   **60-day SMA:** 195.4524

**Analysis:** The stock price closed higher than its previous close. The 5-day SMA is slightly above the 20-day and 60-day SMAs, suggesting a possible short-term upward trend, although the difference is marginal.

**3) RSI, PPO Analysis & Market Risk Indicator**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment Recommended)
*   **RSI (Relative Strength Index):** 55.70
*   **PPO (Percentage Price Oscillator):** -0.01
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** 1.5 (+): 단기상승 (Short-term increase)
*   **Expected Return (%):** -1031.1

**Analysis:**

*   **MRI:** A MRI of 0.8 suggests medium investment risk.
*   **RSI:** The RSI of 55.7 is neutral, indicating neither overbought nor oversold conditions.
*   **PPO:** A PPO of -0.01 suggests that the short-term moving average is slightly below the long-term moving average, potentially indicating a slight downward trend.
*   **Hybrid Signal:** The hybrid signal suggests using the current cash balance to buy 90% of cash of the stock.
*   **Relative Divergence Change:** The positive change in relative divergence over the past 20 days suggests a short-term upward trend relative to the comparison.
*   **Expected Return:** The extremely negative expected return (-1031.1%) is highly concerning and warrants serious investigation. It suggests significant downside risk if holding the stock for more than 2 years

**4) Recent News & Significant Events**

*   **[2025-12-31]** Honeywell (HON) stock slips as Pentagon posts $58.8 million Army contract modification.
*   **[2025-12-16]** Honeywell (HON): Valuation Check After Indra Nooyi Joins the Board of Directors.
*   **[2025-12-22]** Honeywell says it has a $470 million Flexjet problem, and a lowered profit outlook.
*   **[2025-12-05]** HON Stock vs. 3M: Which Industrial Giant Looks Stronger in 2025
*   **[2026-01-03]** Synergy Asset Management LLC Increases Holdings in Honeywell International Inc. $HON
*   **[2026-01-03]** Barclays Sees Renewed Investor Interest in Honeywell (HON) into Spring 2026

**Analysis:**

*   The news is mixed. A contract modification with the Pentagon caused a slight stock slip. Indra Nooyi joining the board prompts a valuation check. The Flexjet issue and lowered profit outlook are negative signals. A fund increased holdings, and Barclays sees renewed investor interest.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (~2.07 on a 1-5 scale)
*   **Opinions:** 24 Analysts
*   **Target Price:** Avg: 236.61, High: 271.00, Low: 195.00
*   **Recent Rating Changes:** No Changes Listed

**Analysis:**

*   Analysts generally have a "Buy" consensus on HON.
*   The average target price is higher than the current price, suggesting potential upside. However, the low target price is essentially at the current price.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-10-23 | 2.87 | 10.41 B$   |
| 2025-07-24 | 2.46 | 10.35 B$   |
| 2025-04-29 | 2.24 | 9.82 B$    |
| 2024-10-24 | 2.17 | 9.73 B$    |
| 2025-10-23 | 2.17 | 9.73 B$ |

**Analysis:**

*   EPS (Earnings Per Share) and Revenue (매출) have generally been increasing, particularly in the most recent quarter.
*   Revenue has shown consistent growth over the provided quarters.

**6) Financial Information: Revenue and Profitability & Capital and Profitability**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $10.41B    | 34.08%        |
| 2025-06-30   | $10.35B    | 38.86%        |
| 2025-03-31   | $9.82B     | 38.54%        |
| 2024-12-31   | $10.09B    | 36.38%        |
| 2024-09-30   | $9.73B     | 38.54%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-09-30   | $16.78B    | 10.87%   |
| 2025-06-30   | $16.09B    | 9.75%    |
| 2025-03-31   | $17.46B    | 8.30%    |
| 2024-12-31   | $18.62B    | 6.90%    |
| 2024-09-30   | $17.41B    | 8.12%    |

**Analysis:**

*   **Revenue and Profitability:**  Revenue has generally increased over the past five quarters. Profit margins are relatively high, but fluctuate.
*   **Capital and Profitability:**  Equity has decreased over the period, while ROE (Return on Equity) has generally increased.

**7) Comprehensive Analysis (Summary)**

*   **Underperformance:** HON has significantly underperformed the S&P 500.
*   **Mixed Signals:** Analyst ratings are generally positive, but news headlines are mixed, with concerns about Flexjet and lowered profit outlook.
*   **Financial Performance:** Revenue and EPS are growing, but equity is decreasing.
*   **Technical Indicators:** RSI is neutral, PPO suggests a slight downward trend, and the MRI indicates medium investment risk. The expected return is extremely negative and requires further investigation.
*   **Key Concern:** The extremely negative expected return and recent underperformance are significant red flags. While analyst consensus is positive, the data suggests caution and warrants further due diligence. The Flexjet problem and lowered profit outlook are also points of concern.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.